You are here:
25 April 2019 / deal

Loyens & Loeff advised Eurazeo Capital on the acquisition of DORC Group from Montagu

Loyens & Loeff advised Eurazeo Capital, a France-based, leading global investment company listed on Euronext Paris, on the acquisition of DORC (Dutch Ophthalmic Research Center) a Netherlands-based company which operates in the medical technology sector and designs, manufactures and distributes ophthalmic surgery equipment, from Montagu Private Equity, a European private equity firm with headquarters in London.

Eurazeo Capital will invest close to 300M€ in this transaction. DORC will be the fifth investment of Eurazeo Capital IV. This investment perfectly fits the strategy presented during the 2018 Annual Results presentation.

Building windows three colors


EUTA Special Edition: EU responses to COVID-19 crisis

The COVID-19 (Coronavirus) pandemic is affecting hundreds of thousands of people and is leading, all over the world, to far-reaching health and safety measures.... read more

Optional deferral of the EU Mandatory Disclosure Directive reporting obligations

On 24 June 2020, the Council of the European Union (the Council) adopted an amendment to the Mandatory Disclosure Directive ((Directive (EU) 2018/855) the Directive)... read more

Dutch UBO-register bill approved by Senate

Het wetsvoorstel ‘Implementatie registratie van uiteindelijk belanghebbende van vennootschappen en andere juridische entiteiten’ is aangenomen. read more